Liminal BioSciences Inc. PFSCF

Primary Symbol: LMNL

Healthcare Biotechnology

Liminal BioSciences is a biopharmaceutical company focused on the discovery and development of novel, small molecule drug candidates for the treatment of patients suffering from fibrotic or inflammatory diseases that have a high unmet medical need. Liminal BioSciences operates on an integrated basis from our talent hubs in Laval, Quebec, Canada, and Cambridge, UK. Our common shares are listed for trading on the Nasdaq Global Market.

NDAQ:LMNL - Post by User

Liminal BioSciences Inc.

Bullboard Posts

Comment by francois21on Feb 19, 2014 6:36pm

182 Views

Post# 22227397

RE: 1.23Change: 0.03 (2.50%)Volume: 1,097 PFSCF

Skyhigh, don't waste time with the OTC market. It's a secondary stock market, that'a all. Until PLI isn't listed on the NASDAQ, the american market will give no value to the stock.

Bullboard Posts

Quebecor achieves all Freedom Mobile acquisition commitments